STRATA Skin Sciences' TheraClearX Treatment For Acne Gets Regulatory Approval From Mexico's Health Authority Through November 2029
Benzinga Newsdesk 1 year ago
News
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies for the treatment of skin conditions such as acne, psoriasis, and vitiligo, today announced that its TheraClearX®
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies for the treatment of skin conditions such as acne, psoriasis, and vitiligo, today announced that its TheraClearX® acne treatment system has received regulatory clearance from the Mexican health authority, COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), under Device Registration No. 3187E2024SSA, valid through November 2029.
This certification represents a major milestone in STRATA's international expansion strategy, officially authorizing the importation, commercialization, and clinical use of TheraClearX® across Mexico's medical and aesthetic markets.